Cargando…

Effects of HMGB1 Polymorphisms on the Susceptibility and Progression of Hepatocellular Carcinoma

Hepatocellular carcinoma (HCC) is a malignancy of liver and a leading cause of cancer mortality worldwide. Its management is compounded by biological and clinical heterogeneity. These interindividual genetic variations can modulate the effects of HCC treatment. High-mobility group box protein 1 (HMG...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Bin, Yeh, Chao-Bin, Lein, Ming-Yu, Su, Chen-Ming, Yang, Shun-Fa, Liu, Yu-Fan, Tang, Chih-Hsin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Ivyspring International Publisher 2016
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4829544/ https://www.ncbi.nlm.nih.gov/pubmed/27076788 http://dx.doi.org/10.7150/ijms.14877

Ejemplares similares

Impacts of CCL4 gene polymorphisms on hepatocellular carcinoma susceptibility and development
por: Wang, Bin, et al.
Publicado: (2017)

Effects of RAGE Gene Polymorphisms on the Risk and Progression of Hepatocellular Carcinoma
por: Su, Shih-Chi, et al.
Publicado: (2015)

Effect of RECK Gene Polymorphisms on Hepatocellular Carcinoma Susceptibility and Clinicopathologic Features
por: Chung, Tsung-Te, et al.
Publicado: (2012)

Impact of matrix metalloproteinase-11 gene polymorphisms upon the development and progression of hepatocellular carcinoma
por: Wang, Bin, et al.
Publicado: (2018)

Association of HMGB1 Gene Polymorphisms with Lung Cancer Susceptibility and Clinical Aspects
por: Hu, Weiwei, et al.
Publicado: (2017)

Association between Interleukin-18 Polymorphisms and Hepatocellular Carcinoma Occurrence and Clinical Progression
por: Lau, Hon-Kit, et al.
Publicado: (2016)

Serpin peptidase inhibitor (SERPINB5) haplotypes are associated with susceptibility to hepatocellular carcinoma
por: Yang, Shun-Fa, et al.
Publicado: (2016)

HMGB1 genetic polymorphisms are biomarkers for the development and progression of breast cancer
por: Huang, Bi-Fei, et al.
Publicado: (2018)

Effects of ADAMTS14 genetic polymorphism and cigarette smoking on the clinicopathologic development of hepatocellular carcinoma
por: Sheu, Ming-Jen, et al.
Publicado: (2017)

Variations in the AURKA Gene: Biomarkers for the Development and Progression of Hepatocellular Carcinoma
por: Wang, Bin, et al.
Publicado: (2018)

Effects of NFKB1 and NFKBIA Gene Polymorphisms on Hepatocellular Carcinoma Susceptibility and Clinicopathological Features
por: Cheng, Chao-Wen, et al.
Publicado: (2013)

Effect of HMGB1 Polymorphisms on Urothelial Cell Carcinoma Susceptibility and Clinicopathological Characteristics
por: Hung, Sheng-Chun, et al.
Publicado: (2018)

Genetic Polymorphisms of lncRNA LINC00673 as Predictors of Hepatocellular Carcinoma Progression in an Elderly Population
por: Yuan, Lan-Ting, et al.
Publicado: (2022)

Association of Resistin Gene Polymorphisms with Oral Squamous Cell Carcinoma Progression and Development
por: Yang, Wei-Hung, et al.
Publicado: (2018)

Correlation of Chitinase 3-Like 1 Single Nucleotide Polymorphisms with Hepatocellular Carcinoma in Taiwan
por: Huang, Wayne Shih-Wei, et al.
Publicado: (2017)

Impact of ADAM10 gene polymorphisms on hepatocellular carcinoma development and clinical characteristics
por: Shiu, Jr-Shiang, et al.
Publicado: (2018)

CD44 Gene Polymorphisms on Hepatocellular Carcinoma Susceptibility and Clinicopathologic Features
por: Chou, Ying-Erh, et al.
Publicado: (2014)

Effects of EZH2 Polymorphisms on Susceptibility to and Pathological Development of Hepatocellular Carcinoma
por: Yu, Yung-Luen, et al.
Publicado: (2013)

The Impact of HMGB1 Polymorphisms on Prostate Cancer Progression and Clinicopathological Characteristics
por: Chou, Ying-Erh, et al.
Publicado: (2020)

Resistin polymorphisms are associated with rheumatoid arthritis susceptibility in Chinese Han subjects
por: Wang, Lihong, et al.
Publicado: (2018)

Association of EGFR mutations and HMGB1 genetic polymorphisms in lung adenocarcinoma patients
por: Wu, Yi-Liang, et al.
Publicado: (2019)

MicroRNA Gene Polymorphisms and Environmental Factors Increase Patient Susceptibility to Hepatocellular Carcinoma
por: Chu, Yin-Hung, et al.
Publicado: (2014)

A functional variant at the miRNA binding site in HMGB1 gene is associated with risk of oral squamous cell carcinoma
por: Lin, Chiao-Wen, et al.
Publicado: (2017)

Glutathione S-Transferase P1 (GSTP1) gene polymorphism increases age-related susceptibility to hepatocellular carcinoma
por: Chen, Yao-Li, et al.
Publicado: (2010)

Terminalia catappa attenuates urokinase-type plasminogen activator expression through Erk pathways in Hepatocellular carcinoma
por: Yeh, Chao-Bin, et al.
Publicado: (2014)

Association of melatonin membrane receptor 1A/1B gene polymorphisms with the occurrence and metastasis of hepatocellular carcinoma
por: Su, Shih-Chi, et al.
Publicado: (2017)

Impact of EZH2 Polymorphisms on Urothelial Cell Carcinoma Susceptibility and Clinicopathologic Features
por: Yu, Yung-Luen, et al.
Publicado: (2014)

Antimetastatic Effects of Norcantharidin on Hepatocellular Carcinoma by Transcriptional Inhibition of MMP-9 through Modulation of NF-kB Activity
por: Yeh, Chao-Bin, et al.
Publicado: (2012)

Functional FGFR4 Gly388Arg polymorphism contributes to oral squamous cell carcinoma susceptibility
por: Chou, Chia-Hsuan, et al.
Publicado: (2017)

Impact of VEGF-C Gene Polymorphisms and Environmental Factors on Oral Cancer Susceptibility in Taiwan
por: Chien, Ming-Hsien, et al.
Publicado: (2013)

Functional genetic variant of WW domain-containing oxidoreductase (WWOX) gene is associated with hepatocellular carcinoma risk
por: Lee, Hsiang-Lin, et al.
Publicado: (2017)

Correction: Antimetastatic Effects of Norcantharidin on Hepatocellular Carcinoma by Transcriptional Inhibition of MMP-9 through Modulation of NF-kB Activity
por: Yeh, Chao-Bin, et al.
Publicado: (2017)

Effects of MACC1 polymorphisms on hepatocellular carcinoma development and clinical characteristics
por: Lin, Chien-Hua, et al.
Publicado: (2020)

Visfatin Polymorphisms, Lifestyle Risk Factors and Risk of Oral Squamous Cell Carcinoma in a Cohort of Taiwanese Males
por: Chen, Kwei-Jing, et al.
Publicado: (2022)

Rs4938723 Polymorphism Is Associated with Susceptibility to Hepatocellular Carcinoma Risk and Is a Protective Factor in Leukemia, Colorectal, and Esophageal Cancer
por: Xu, Bin, et al.
Publicado: (2018)

Combined Effects of ICAM-1 Single-Nucleotide Polymorphisms and Environmental Carcinogens on Oral Cancer Susceptibility and Clinicopathologic Development
por: Lin, Chiao-Wen, et al.
Publicado: (2013)

Association of lncRNA H19 Gene Polymorphisms with the Occurrence of Hepatocellular Carcinoma
por: Wu, Edie-Rosmin, et al.
Publicado: (2019)

Association of lncRNA CCAT2 and CASC8 Gene Polymorphisms with Hepatocellular Carcinoma
por: Wu, Edie-Rosmin, et al.
Publicado: (2019)

Evaluation of the Risk Factors for Cellulitis among Patients with Peripheral Artery Disease
por: Wang, Bo-Yuan, et al.
Publicado: (2023)

The Antimetastatic Effects of Resveratrol on Hepatocellular Carcinoma through the Downregulation of a Metastasis-Associated Protease by SP-1 Modulation
por: Yeh, Chao-Bin, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_7tm9j4jb8snar3mm3mif8euovb